Future theranostic strategies: emerging ovarian cancer biomarkers to bridge the gap between diagnosis and treatment

W Rajapaksha, R Khetan, IRD Johnson… - Frontiers in Drug …, 2024 - frontiersin.org
Ovarian cancers are a complex and heterogenic group of malignancies that are difficult to
detect, diagnose and treat. Fortunately, considerable knowledge of ovarian cancer specific …

Meaningful Transparency for Clinicians: Operationalising HCXAI Research with Gynaecologists

BGS Schor, E Kallina, J Singh, A Blackwell - The 2024 ACM Conference …, 2024 - dl.acm.org
AI systems can bring great benefits to our healthcare systems, eg by improving patient
outcomes. Yet implementing them into clinical practice remains challenging. To bridge the …

Cytoreductive surgery and perioperative intraperitoneal chemotherapy in recurrent ovarian cancer: 18 years of experience

A Liberis, D Kyziridis, A Kalakonas… - European Journal of …, 2024 - Elsevier
Aim To identify the clinical and pathological factors associated with relapse in women who
had undergone secondary cytoreductive surgery due to locally advanced recurrent ovarian …

Empirical evidence of the task-adapted reconstruction framework for joint CT reconstruction and segmentation

E Valat, A Biguri, LE Sanchez, C McCague… - Applied Mathematics …, 2024 - aimsciences.org
Powered by machine learning, computer-aided diagnostics support clinicians by
streamlining their work. In cancer screening, for instance, this technique often involves an …

Augmented Radiology in High Grade Serous Ovarian Carcinoma

C McCague - 2024 - repository.cam.ac.uk
Radiological imaging is at the centre of how modern medical care is delivered and provides
a unique perspective on disease: it is non-invasively attained, gives 3-dimensional spatially …